Warning: Declaration of My_Walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $data_object, $depth = 0, $args = NULL, $current_object_id = 0) in /home2/ajnrblog/public_html/ajnrdigest/wp-content/themes/ajnr/functions.php on line 258
IgG4-Related Inflammatory Pseudotumor of the Trigeminal Nerve: Another Component of IgG4-Related Sclerosing Disease? - AJNR News Digest
November-December 2015
Case Report

IgG4-Related Inflammatory Pseudotumor of the Trigeminal Nerve: Another Component of IgG4-Related Sclerosing Disease?

Masaki Katsura, MD

Masaki Katsura, MD

Immunoglobulin G4 is the rarest of the 4 subclasses of serum IgG. Little attention had been paid to this minor component of IgG until Hamano et al1 found that patients with autoimmune pancreatitis (AIP) display high serum concentrations of IgG4. The same group also reported that pancreatic tissues in patients with AIP were histologically characterized by sclerosing inflammation with infiltration of numerous plasma cells that show strong immunoreactivity to IgG4.2 Several subgroups of extrapancreatic lesions that share similar pathologic features with AIP have been discovered in various organs and sites, such as the biliary duct,3 retroperitoneum,4, and lung.5 In the head and neck region, these types of lesions have been found most frequently in the lacrimal, parotid, submandibular, and pituitary glands,6–8 but nasal/paranasal9 and parapharyngeal10 lesions have also been reported. Given the similar pathologic features and frequent association with multiple lesions in different organs, a new designation, systemic IgG4-related sclerosing disease, has been established as a distinct clinicopathologic entity.11

Our report describes a case of IgG4-related inflammatory pseudotumor involving the skull base along the second and third divisions of the left trigeminal nerve. MR imaging demonstrated a well-defined, T2-hypointense mass in the left Meckel cave, extending to the left pterygopalatine fossa via the left foramen rotundum and further to the infraorbital canal. The mass also extended to the left masticator space via the left foramen ovale. The mass accompanied expansion of neural foramina along its course, notably the foramen rotundum and the infraorbital canal, with no signs of bone destruction. The pathologic specimen taken from the pterygopalatine fossa showed a dense inflammatory infiltrate with abundant IgG4+ plasma cell infiltration along the trigeminal nerve fibers, indicating perineural spread as the underlying pathology.

Differentiating IgG4-related disease from primary/metastatic neoplasms can be challenging. Particularly in our case, the lesion showed extensive perineural spread along the trigeminal nerve, highly suggestive of a neoplastic process. Although a definitive diagnosis requires pathologic confirmation, IgG4-related disease can be suspected on imaging by recognizing typical radiologic features,12–14 such as well-defined lesion borders, homogeneous attenuation/signal intensity, T2 hypointensity (possibly explained by the combination of fibrosis and attenuated cellularity), homogeneous and gradual enhancement pattern, absence of vascular occlusion or compression, and presence of bone remodeling (erosion or sclerosis) without destruction (probably due to the slow-growing nature and to the long-standing mechanical stress/pressure induced by the lesions within the neural foramina). Patients with IgG4-related disease frequently have lesions in areas other than the head and neck (either simultaneously or in the past), such as in the pancreas, biliary duct, retroperitoneum, kidney, and lung. Recognition of these preferential sites for IgG4-related disease can be of help in the differential diagnosis. If serologic studies show markedly increased serum IgG4 levels, the diagnosis of IgG4-related disease may be further supported. We believe

that, in practical clinical cases, detailed review of the clinical presentation, medical history, and laboratory findings, as well as extensive physical examinations are necessary. Because IgG4-related disease usually has a benign clinical course with steroid treatment,15 it is important to consider this diagnosis for appropriate clinical decision making.

Reference

  1. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–38, 10.1056/NEJM200103083441005
  2. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002;359:1403–04, 10.1016/S0140-6736(02)08359-9
  3. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28:1193–1203
  4. Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009;33:1833–39, 10.1097/PAS.0b013e3181b72882
  5. Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009;33:1886–93, 10.1097/PAS.0b013e3181bd535b
  6. Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related sclerosing disease? Am J Surg Pathol 2007;31:643–45, 10.1097/01.pas.0000213445.08902.11
  7. Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol 2005;29:783–91
  8. Wong S, Lam WY, Wong WK, et al. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 2007;38:1720–23, 10.1016/j.humpath.2007.06.011
  9. Ishida M, Hotta M, Kushima R, et al. Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int 2009;59:670–75, 10.1111/j.1440-1827.2009.02425.x
  10. Maruya S, Miura K, Tada Y, et al. Inflammatory pseudotumor of the parapharyngeal space: a case report. Auris Nasus Larynx 2010;37:397–400, 10.1016/j.anl.2009.08.002
  11. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006;41: 613–25, 10.1007/s00535-006-1862-6
  12. Toyoda K, Oba H, Kutomi K, et al. MR imaging of IgG4-related disease in the head and neck and brain. AJNR Am J Neuroradiol 2012;33:2136–39, 10.3174/ajnr.A3147
  13. Katsura M, Mori H, Kunimatsu A, et al. Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology 2012;54:873–82, 10.1007/s00234-012-1012-1
  14. Fujita A, Sakai O, Chapman MN, et al. IgG4-related disease of the head and neck: CT and MR imaging manifestations. Radiographics 2012;32:1945–58, 10.1148/rg.327125032
  15. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58:1504–07, 10.1136/gut.2008.172908

 

Read this article at AJNR.org …